Hims & Hers Health, Inc. (HIMS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look ...

Analysts have recently evaluated Hims & Hers Health and provided 12-month price targets. The average target is $19.5, ...

Chief Commercial Officer Michael Chi executed a sale of 25,549 shares of Hims & Hers Health Inc (NYSE:HIMS) on June 18, 2024, ...

Hims & Hers Health is up around 33% since the announcement that it will offer GLP-1 Injections. Read why I rate HIMS stock a ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Hims & Hers Health (HIMS – Research Report), Cogent Biosciences (COGT – Research Report) and Disc Medicine (IRON – ...

Content Brought to You in Partnership with Hims Dealing with hair loss is more than a matter of looks – it's about regaining confidence, reclaiming your identity, and enjoying the peace of mind that ...

Hims & Hers faces challenges with competition and customer retention. Click here to read why HIMS becomes a very dangerous ...

Hims & Hers Health Inc. (NYSE:HIMS) has begun to attract a lot of attention from the market following its recent ...

Keeps and Hims are two popular telehealth companies that offer hair loss treatments for men. Here’s how they compare.